Functional imaging of the brain in patients with liver cirrhosis

Metabolic Brain Disease

Volumn 19, Issue 3-4, 2004, Pages 269-280

  Weissenborn, Karin ^a   Bokemeyer, Martin ^a   Ahl, Björn ^a   Fischer Wasels, Daniela ^a   Giewekemeyer, Kathrin ^a   Van Den Hoff, Jörg ^a   Köstler, Herbert ^a   Berding, Georg ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

brain imaging; Hepatic encephalopathy; MRI; MRS; PET; SPECT

Indexed keywords

AMMONIA; FLUORODEOXYGLUCOSE F 18; MANGANESE;

ATTENTION DEFICIT DISORDER; BASAL GANGLION; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN METABOLISM; CEREBELLUM; CINGULATE GYRUS; CONFERENCE PAPER; DEPTH PERCEPTION; GLUCOSE UTILIZATION; HEPATIC ENCEPHALOPATHY; HIPPOCAMPUS; HUMAN; LIVER CIRRHOSIS; MOTOR PERFORMANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OCCIPITAL CORTEX; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AMMONIA; BRAIN; COGNITION DISORDERS; GLUCOSE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER CIRRHOSIS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 5444229806     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MEBR.0000043976.17500.8e     Document Type: Conference Paper

References (59)

1. Adams, R.D., and Foley, J.M. (1953). The neurological disorders associated with liver disease. Proc. Assoc. Res. Nerv. Ment. Dis. 32:198-237.
2. 2O-and glucose-PET in cirrhotics with minimal hepatic encephalopathy (HE) [abstract]. J. Hepatol. 32(Suppl. 2):146.
3. Balata, S., Olde Damink, S.W.M., Ferguson, K., Marshall, I., Hayes, P.C., Deutz, N.E.P., Williams, R., Wardlaw, J., and Jalan, R. (2003). Induced hyperammmonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis. Hepatology 37:931-939.
4. Butterworth, R.F. (2000). Complications of cirrhosis: III. Hepatic encephalopathy. J. Hepatol. 32(Suppl. 1):171-180.
5. Catafau, A.M., Kulisevsky, J., Berna, L., Pujol, J., Martin, J.C., Otermin, P., Balanzo, J., and Carrio, I. (2000). Relationship between cerebral perfusion in frontal-limbic-basal ganglia circuits and neuropsychological impairment in patients with subclinical hepatic encephalopathy. J. Nucl. Med. 41:405-410.
6. Cordoba, J., Alonso, J., Rovira, A., Jacas, C., Sanpedro, F., Castells, L., Vargas, V., Margarit, C., Kulisewsky, J., Esteban, R., and Guardia, J. (2001a). The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J. Hepatol. 35(5):598-604.
7. Cordoba, J., Olive, G., Alonso, J., Rovira, A., Segarra, A., Perez, M., Jacas, C., and Vargas, V. (2001b). Improvement of magnetic resonance spectroscopic abnormalities but not pallidal hyperintensity followed amelioration of hepatic encephalopathy after occlusion of a large spleno-renal shunt. J. Hepatol. 34(1):176-178.
8. Cordoba, J., Sanpedro, F., Alonso, J., and Rovira, A. (2002). 1H magnetic resonance in the study of hepatic encephalopathy in humans. Metab. Brain Dis. 17(4):415-429.
9. Delcker, A., Turowski, B., Mihm, U., Raab, P., Rusch, O., Pilatus, U., Zeuzem, S., and Zanella, F.E. (2002). Proton MR spectroscopy of neurometabolites in hepatic encephalopathy during L-ornithine-L-aspartate treatment - Results of a pilot study. Metab. Brain Dis. 17(2):103-111.
10. Ferenci, P., Lockwood, A., Mullen, K., Tarter, R., Weissenborn, K., and Blei, A.T. (2002). Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35(3):716-721.
11. Fischer-Wasels, D., Burchert, W., Köstler, H., Ahl, B., van den Hoff, J., and Weissenborn, K. (2000). Comparison Between MRI, MRS, 18-FDG- and 13-NH3-PET data in cirrhotics with minimal hepatic encephalopathy (HE) [abstract]. J. Hepatol. 32(Suppl. 2):64.
12. Haseler, L.J., Sibbitt, W.L., Mojtahedzadeh, H.N., Reddy, S., Agarwal, V.P., and McCarthy, D.M. (1998). Proton MR spectroscopic measurement of neurometabolites in hepatic encephalopathy during oral lactulose therapy. AJNR Am. J. Neuroradiol. 19:1681-1686.
13. Häussinger, D., Kircheis, G., Fischer, R., Schliess, F., and vom Dahl, S. (2000). Hepatic encephalopathy in chronic liver disease: A clinical manifestation of astrocyte swelling and low-grade cerebral edema? J. Hepatol. 32:1035-1038.
14. Häussinger, D., Laubenberger, J., vom Dahl, S., Ernst, T., Bayer, S., Langer, M., Gerok, W., and Hennig, J. (1994). Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology 107(5):1475-1480.
15. Häussinger, D., and Schliess, F. (1999). Osmotic induction of signalling cascades: Role in regulation of cell function. Biochem. Biophys. Res. Commun. 255:551-555.
16. Hazell, A.S. (2002). Astrocytes and manganese neurotoxicity. Neurochem. Int. 41(4):271-277.
17. Hazell, A.S., and Butterworth, R.F. (1999). Hepatic encephalopathy: An update of pathophysiologic mechanisms. PSEBM 222:99-112.
18. Hazell, A.S., Desjardins, P., and Butterworth, R.F. (1999a). Exposure of primary astrocyte cultures to manganese results in increased binding sites for "peripheral-type" benzodiazepine receptor ligands. Neurosci. Lett. 271:5-8.
19. Hazell, A.S., Desjardins, P., and Butterworth, R.F. (1999b). Increased expression of glyceraldehyde-3-phosphate dehydrogenase in cultured astrocytes following exposure to manganese. Neurochem. Int. 35:11-17.
20. Huda, A., Thomas, A., Bugbee, M., Ke, Y., Oshiro, T., Strouse, T., Curran, J., and Guze, B. (1995). Regional variations of metabolites in hepatic encephalopathy [abstract]. Soc. Magn. Reson. 3:1838.
21. Iwasa, M., Kaito, M., Adachi, Y., Watanabe, Y., Matsumura, K., and Takeda, K. (2002). Cerebral blood flow in basal ganglia is correlated with clinical signs of hepatic encephalopathy in patients with liver cirrhosis. Am. J. Gastroenterol. 97(3):763-764.
22. Iwasa, M., Matsumura, K., Kaito, M., Ikoma, J., Kobayashi, Y., Nakagawa, N., Watanabe, S., Takeda, K., and Adachi, Y. (2000). Decrease of regional cerebral blood flow in liver cirrhosis. Eur. J. Gastroenterol. Hepatol. 12(9):1001-1006.
23. Iwasa, M., Matsumura, K., Watanabe, Y., Yamamoto, M., Kaito, M., Ikoma, J., Gavazza, E.C., Takeda, K., and Adachi, Y. (2003). Improvement of regional cerebral blood flow after treatment with branched-chain amino acid solutions in patients with cirrhosis. Eur. J. Gastroenterol. Hepatol. 15:733-737.
24. Jones, E.A., and Basile, A.S. (1998). Does ammonia contribute to increased GABA-ergic neurotransmission in liver failure? Metab. Brain Dis. 13(4):351-360.
25. Jones, E.A., and Weissenborn, K. (1997). Neurology and the liver. J. Neurol. Neurosurg. Psychiatry 63:279-293.
26. Köstler, H. (1998). Proton magnetic resonance spectroscopy in portal-systemic encephalopathy. Metab. Brain Dis. 13(4):291-301.
27. Kreis, R., Ross, B.D., Farrow, N.A., and Ackerman, Z. (1992). Metabolic disorder of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 182:19-27.
28. Krieger, D., Krieger, S., Jansen, O., Gass, P., Theilmann, L., and Lichtnecker, H. (1995). Manganese and chronic hepatic encephalopathy. Lancet 346:270-274.
29. Lammertsma, A.A. (2001). PET/SPECT: Functional imaging beyond flow. Vision Res. 41:1277-1281.
30. Lee, J.H., Seo, D.W., Lee, Y.S., Kim, S.T., Mun, C.W., Lim, T.H., Min, Y.I., and Suh, D.J. (1999). Proton magnetic resonance spectroscopy (1H-MRS) findings in the brain in patients with liver cirrhosis reflect the hepatic functional reserve. Am. J. Gastroenterol. 94(8):2206-2213.
31. Lockwood, A.H., Murphy, B.W., Donnelly, K.Z., Mahl, T.C., and Perini, S. (1993). Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy. Hepatology 18(5):1061-1068.
32. Lockwood, A.H., Weissenborn, K., Bokemeyer, M., Tietge, U., and Burchert, W. (2002). Correlations between cerebral glucose metabolism and neuropsychological test performance in nonalcoholic cirrhotics. Metab. Brain Dis. 17(1):29-40.
33. Lockwood, A.H., Weissenbom, K., and Butterworth, R.F. (1997). An image of the brain in patients with liver disease. Curr. Opin. Neurol. 10:525-533.
34. Lockwood, A.H., Yap, E.W., and Wong, W.H. (1991a). Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J. Cereb. Blood Flow Metab. 11(2):337-341.
35. Lockwood, A.H., Yap, E.W.H., Rhoades, H.M., and Wong, W.H. (1991b). Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy. J. Cereb. Blood Flow Metab. 11(2):331-336.
36. Martin, H., Voss, K., Hufnagl, P., Wack, R., and Wassilew, G. (1987). Morphometric and densitometric investigations of protoplasmic astrocytes and neurons in human hepatic encephalopathy. Exp. Pathol. 32:241-250.
37. Mirowitz, S.A., Westrich, T.J., and Hirsch, H.D. (1991). Hyperintense basal ganglia on T1-weighted MR images in patients receiving parenteral nutrition. Radiology 181:117-120.
38. Morgan, M.Y. (1998). Cerebral magnetic resonance imaging in patients with chronic liver disease. Metab. Brain Dis. 13(4):273-290.
39. Naegele, T., Grodd, W., Viebahn, R., Seeger, U., Klose, U., Seitz, D., Kaiser, S., Mader, I., Mayer, J., Lauchart, W., Gregor, M., and Voigt, K. (2000). MR imaging and 1H spectroscopy of brain metabolites in hepatic encephalopathy: Time-course of renormalization after liver transplantation. Radiology 216:683-691.
40. Nelson, K., Golnick, J., Korn, T., and Angle, C. (1993). Manganese encephalopathy: Utility of early magnetic resonance imaging. Br. J. Ind. Med. 40:510-513.
41. Norenberg, M.D. (1977). A light and electron microscopic study of experimental portal-systemic (ammonia) encephalopathy. Lab. Invest. 36:618-627.
42. Norenberg, M.D. (1998). Astroglial dysfunction in hepatic encephalopathy. Metab. Brain Dis. 13(4):319-335.
43. Norenberg, M.D., and Bender, A.S. (1994). Astrocyte swelling in liver failure: Role of glutamine and benzodiazepines. Acta Neurochir. 60(Suppl.):24-27.
44. O'Carroll, R.E., Hayes, P.C., Ebmeier, K.P., Dougall, N., Murray, C., Best, J., Bouchier, I.A., and Goodwin, G.M. (1991). Regional cerebral blood flow and cognitive function in patients with chronic liver disease. Lancet 337(8752):1250-1253.
45. Pomier-Layrargues, G., Rose, C., Spahr, L., Zayed, J., Normandin, L., and Butterworth, R.F. (1998). Role of manganese in the pathogenesis of portal-systemic encephalopathy. Metab. Brain Dis. 13(4):311-317.
46. Pomier-Layrargues, G., Spahr, L., and Butterworth, R.F. (1995). Increased manganese concentrations in pallidum of cirrhotic patients. Lancet 345:735.
47. Pujol, J., Kulisevsky, J., Moreno, A., Deus, J., Alonso, J., Balanzo, J., Marti-Vilalta, J.L., and Capdevila, A. (1996). Neurospectroscopic alterations and globus pallidus hyperintensity as related magnetic resonance markers of reversible hepatic encephalopathy. Neurology 47(6):1526-1530.
48. Rose, C., Butterworth, R.F., Zayed, J., Normandin, L., Todd, K., Michalak, A., Spahr, L., Huet, P.M., and Pomier-Layrargues, G. (1999). Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 117:640-644.
49. Rovira, A., Grive, E., Pedraza, S., Rovira, A., and Alonso, J. (2001). Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis. Am. J. Neuroradiol. 22:1137-1142.
50. Schomerus, H., Weissenborn, K., Hamster, W., Rückert, N., and Hecker, H. (1999). PSE-Syndrom Test, Swets Test Services, Swets & Zeitlinger, Frankfurt.
51. Spahr, L., Butterworth, R.F., Fontaine, S., Bui, L., Therrien, G., Milette, P.C., Lebrun, L.H., Zayed, J., Leblanc, A., and Pomier-Layrargues, G. (1996). Increased blood manganese in cirrhotic patients: Relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. Hepatology 24:1116-1120.
52. Taylor-Robinson, S.D., Sargentoni, J., Marcus, C.D., Morgan, M.Y., and Bryant, D.J. (1994). Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab. Brain Dis. 10:175-188.
53. Van Laere, K., Versijpt, J., Audenaert, K., Koole, M., Goethls, I., Achten, E., and Dierckx, R. (2001). 99m Tc-ECD brain perfusion SPET: Variability, asymmetry and effects of age and gender in healthy adults. Eur. J. Nucl. Med. 28:873-887.
54. Weissenborn, K., Ehrenheim, C., Hori, A., Kubicka, S., and Manns, M.P. (1995). Pallidal lesions in patients with liver cirrhosis: Clinical and MRI evaluation. Metab. Brain Dis. 10:219-238.
55. Weissenborn, K., Ennen, J.C., Schomeras, H., Rückert, N., and Hecker, H. (2001a). Neuropsychological characterization of hepatic encephalopathy. J. Hepatol. 34(5):768-773.
56. Weissenborn, K., Heidenreich, S., Ennen, J., Rückert, N., and Hecker, H. (2001b). Attention deficits in minimal hepatic encephalopathy. Metab. Brain Dis. 16(1/2):13-19.
57. Weissenborn, K., Heidenreich, S., Giewekemeyer, K., Rückert, N., and Hecker, H. (2003). Memory function in early hepatic encephalopathy. J. Hepatol. 39:320-325.
58. Weissenborn, K., and Kolbe, H. (1998). The basal ganglia and portal-systemic encephalopathy. Metab. Brain Dis. 13(4):261-272.
59. Yazgan, Y., Narin, Y., Demirturk, L., Saracoglu, M., Ercan, M., Akyatan, N., Dalkanat, N., Ozel, A.M., and Cetin, M. (2003). Value of regional cerebral blood flow in the evaluation of chronic liver disease and subclinical hepatic encephalopathy. J. Gastroenterol. Hepatol. 18:1162-1167.